NOVEL

NOVEL is a biotechnology and software development company that integrates molecular biology expertise with advanced data analysis, including artificial intelligence, machine learning, and bioinformatics. Established in 2004, the firm employs a multidisciplinary team of over 50 specialists, including developers, data scientists, and biologists, to provide custom software solutions and research services. Their technical capabilities span web development, complex database architecture, cloud computing, and big data processing, often utilizing frameworks like PyTorch and Scikit-learn. The company operates globally with offices in Russia, the USA, China, and the Netherlands, focusing on the intersection of mathematics, biology, and information technology.

The company serves pharmaceutical organizations, scientific laboratories, and diagnostic centers by solving science-intensive tasks related to genomic, proteomic, and biomedical data. Their work supports critical applications such as medical image processing, drug efficiency prediction, and the analysis of sequencing data. NOVEL develops its own proprietary software products, including Genomenal and Protomenal, and collaborates with leading research institutions to advance personalized medicine and molecular genetic technologies. Their track record includes published research in international scientific journals and participation in prestigious machine learning competitions, reflecting their commitment to both applied industrial solutions and fundamental scientific research.